Chapter 51 Epstein–Barr Virus and Kaposi Sarcoma-Associated Herpesvirus Eric Johannsen, MD Epstein–Barr virus (EBV), the agent of infectious mononucleosis, is associated with the HIV-related syndromes of oral hairy leukoplakia (OHL)…
Chapter 57 JC Virus Neurologic Infection Sunil Chauhan, MD, MsPH, Colin D. Hall, MBChB Progressive multifocal leukoencephalopathy (PML) was initially described by Astrom and colleagues in 1958,1 as a complication…
Chapter 71 Diabetes and Insulin Resistance Colleen Hadigan, MD, MPH, Steven Grinspoon, MD INTRODUCTION Insulin resistance and type 2 diabetes mellitus are increasingly recognized as common among individuals with HIV…
Chapter 49 Varicella-Zoster Virus Infections John W. Gnann, Jr, MD Diseases caused by all human herpesviruses, including varicella-zoster virus (VZV), occur with increased frequency in patients with human immunodeficiency virus…
Chapter 59 Kaposi Sarcoma Susan E. Krown, MD Kaposi sarcoma (KS) was one of the first opportunistic diseases described in association with the acquired immune deficiency syndrome (AIDS).1 Despite a…
Chapter 47 Mycoses Caused by Molds Thomas F. Patterson, MD, John R. Graybill, MD Infections caused by molds are uncommon but important causes of opportunistic infections in patients with advanced…
Chapter 19 Fosamprenavir and Amprenavir Roger Paredes, MD, Lidia Ruiz, PhD, Bonaventura Clotet, MD, PhD INTRODUCTION Protease inhibitors (PIs) are one of the mainstays of HIV/AIDS therapy,1 being largely responsible…
Chapter 43 Cryptococcosis Judith A. Aberg, MD, William G. Powderly, MD Disseminated cryptococcosis has been the most common life-threatening fungal infection in patients with acquired immunodeficiency syndrome (AIDS), affecting up…
